Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Super-Potent Drug: Out of specification potency results were obtained.
Products
  • Levothyroxine Sodium Tablets
Where it was sold

Nationwide in the USA

Nationwide

Units affected
1,068 cartons
About this recall
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.